David Goldblatt

28.0k total citations · 5 hit papers
379 papers, 15.0k citations indexed

About

David Goldblatt is a scholar working on Epidemiology, Microbiology and Immunology. According to data from OpenAlex, David Goldblatt has authored 379 papers receiving a total of 15.0k indexed citations (citations by other indexed papers that have themselves been cited), including 186 papers in Epidemiology, 84 papers in Microbiology and 62 papers in Immunology. Recurrent topics in David Goldblatt's work include Pneumonia and Respiratory Infections (164 papers), Respiratory viral infections research (95 papers) and Bacterial Infections and Vaccines (84 papers). David Goldblatt is often cited by papers focused on Pneumonia and Respiratory Infections (164 papers), Respiratory viral infections research (95 papers) and Bacterial Infections and Vaccines (84 papers). David Goldblatt collaborates with scholars based in United Kingdom, United States and India. David Goldblatt's co-authors include David Held, Jonathan Perraton, Anthony McGrew, G. John Ikenberry, Elizabeth Miller, Nick Andrews, Ray Borrow, Adrian J. Thrasher, Katherine L. O’Brien and Lindsey Ashton and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David Goldblatt

358 papers receiving 14.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Transformations: Politics, Economics, and Culture

1999 1.6k citations David Goldblatt et al. profile →
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

2021 656 citations David Goldblatt et al. profile →
Evidence for antibody as a protective correlate for COVID-19 vaccines

2021 475 citations Donna M. Ambrosino, Andrew Fioré-Gartland et al. Vaccine profile →
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

2014 393 citations Emma Pearce, Lucy Roalfe et al. profile →
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease

2022 163 citations David Goldblatt, Galit Alter et al. profile →

Peers

Countries citing papers authored by David Goldblatt

Since Specialization

Citations

This map shows the geographic impact of David Goldblatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Goldblatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Goldblatt more than expected).

Fields of papers citing papers by David Goldblatt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Goldblatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Goldblatt. The network helps show where David Goldblatt may publish in the future.

Co-authorship network of co-authors of David Goldblatt

This figure shows the co-authorship network connecting the top 25 collaborators of David Goldblatt. A scholar is included among the top collaborators of David Goldblatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Goldblatt. David Goldblatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and Immunogenicity of a Klebsiella pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V) Administered to Healthy Adults: A First-in-Human Phase I/II Randomized and Controlled Study 2025 ·The Journal of Infectious Diseases ·Cristina Alaimo, (unknown), (unknown), (unknown), (unknown), Michael Kowarik, David Goldblatt, Patricia Martín	0
2	Natural immunity and protection against variants in South African children through five COVID-19 waves: A prospective study 2024 ·International Journal of Infectious Diseases ·Heather J. Zar, Lesley Workman, Rae MacGinty, Maresa Botha, Marina Johnson, Adam Hunt, (unknown), Mark P. Nicol, Stefan Flasche, Billy J. Quilty, David Goldblatt	0
3	Immunization with a whole cell vaccine reduces pneumococcal nasopharyngeal density and shedding, and middle ear infection in mice 2024 ·Vaccine ·(unknown), Sam Manna, Eileen M. Dunne, (unknown), Casey L. Pell, Natalie L. Patterson, (unknown), Poshmaal Dhar, David Goldblatt, Kim Mulholland, Paul V. Licciardi, Roy M. Robins‐Browne, Richard Malley, Odilia Wijburg, Catherine Satzke	1
4	Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children 2023 ·Vaccine ·Anand Kawade, (unknown), (unknown), (unknown), (unknown), Emma Pearce, Lucy Roalfe, (unknown), Yanyun Wang, Navideh Noori, (unknown), Sanjay Juvekar, Assaf P. Oron, Sonali Sanghavi, David Goldblatt, Ron Dagan, Ashish Bavdekar	9
5	Defective Monocyte Enzymatic Function and an Inhibitory Immune Phenotype in Human Immunodeficiency Virus-Exposed Uninfected African Infants in the Era of Antiretroviral Therapy 2022 ·The Journal of Infectious Diseases ·(unknown), Kondwani Jambo, (unknown), David J. C. Miles, Anmol Kiran, Dominic H. Banda, (unknown), Dumizulu Tembo, Annette Pachnio, Eleni Nastouli, (unknown), Henry C. Mwandumba, Paul Moss, David Goldblatt, Sarah Rowland‐Jones, Adam Finn, Robert S. Heyderman	8
6	High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster 2022 ·The Journal of Infectious Diseases ·(unknown), Shixia Wang, (unknown), (unknown), (unknown), (unknown), Lixia Wang, Marina Johnson, Adam Hunt, (unknown), Thomas P. Monath, (unknown), David Goldblatt	15
7	SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children 2022 ·Science Translational Medicine ·Yannic C. Bartsch, Kerri St. Denis, Paulina Kapłonek, Jaewon Kang, Evan C. Lam, Madeleine D. Burns, E Farkas, Jameson P. Davis, Brittany P. Boribong, Andrea G. Edlow, Alessio Fasano, Wayne G. Shreffler, Dace Zavadska, Marina Johnson, David Goldblatt, Alejandro B. Balazs, Lael M. Yonker, Galit Alter	31
8	Novel Multilocus Sequence Typing and Global Sequence Clustering Schemes for Characterizing the Population Diversity of Streptococcus mitis 2022 ·Journal of Clinical Microbiology ·(unknown), Brenda Kwambana-Adams, Jia Mun Chan, (unknown), Andrea Gori, Damien Richard, Keith A. Jolley, John A. Lees, David Goldblatt, Sandra Beleza, Stephen D. Bentley, Robert S. Heyderman, Chrispin Chaguza	3
9	Streptococcus pneumoniae serotypes that frequently colonise the human nasopharynx are common recipients of penicillin-binding protein gene fragments from Streptococcus mitis 2021 ·Microbial Genomics ·(unknown), Chrispin Chaguza, Andrea Gori, (unknown), Sandra Beleza, Martín Antonio, Bernard Beall, David Goldblatt, Brenda Kwambana-Adams, Stephen D. Bentley, Robert S. Heyderman	14
10	Protective Effect of Nasal Colonisation with ∆cps/piaA and ∆cps/proABCStreptococcus pneumoniae Strains against Recolonisation and Invasive Infection 2021 ·Vaccines ·Elisa Ramos‐Sevillano, Giuseppe Ercoli, José Afonso Guerra‐Assunção, Philip L. Felgner, Rafael Ramiro de Assis, Rie Nakajima, David Goldblatt, (unknown), Robert S. Heyderman, Stephen B. Gordon, (unknown), Jeremy Brown	4
11	Towards a population-based threshold of protection for COVID-19 vaccines 2021 ·Vaccine ·David Goldblatt, Andrew Fioré-Gartland, Marina Johnson, Adam Hunt, Christopher Bengt, Dace Zavadska, (unknown), Jeremy Brown, Lesley Workman, Heather J. Zar, David C. Montefiori, Xiaoying Shen, Peter Dull, Stanley A. Plotkin, George R. Siber, Donna M. Ambrosino	87
12	A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults 2020 ·The Pediatric Infectious Disease Journal ·Cheryl Keech, (unknown), Porter Anderson, (unknown), Jorge Flores, David Goldblatt, David E. Briles, John Hural, Richard Malley, Mark R. Alderson	19
13	Thirteen-Valent Pneumococcal Conjugate Vaccine in Children With Acute Lymphoblastic Leukemia: Protective Immunity Can Be Achieved on Completion of Treatment 2019 ·Clinical Infectious Diseases ·Jessica Bate, Ray Borrow, Julia Chisholm, Stuart C. Clarke, Elizabeth Dixon, Saul N. Faust, (unknown), David Goldblatt, Paul T. Heath, Tom Maishman, (unknown), Soonie R Patel, (unknown), Juliet C. Gray	9
14	The Aesthetics of Architecture : Philosophical Investigations into the Art of Building 2011 ·Wiley-Blackwell eBooks ·David Goldblatt, Roger Paden	3
15	The football book : the leagues, the teams, the tactics, the laws 2009 ·David Goldblatt, (unknown)	0
16	Human γδ T Cells: A Lymphoid Lineage Cell Capable of Professional Phagocytosis 2009 ·The Journal of Immunology ·Yin Wu, Wutian Wu, Wai Man Wong, (unknown), Adrian J. Thrasher, David Goldblatt, Mohamed Osman, Paul Digard, David H. Canaday, Kenth Gustafsson	119
17	Chronic Granulomatous Disease: from genetic defect to clinical presentation in hot topics in infection and immunity in children 2005 ·UCL Discovery (University College London) ·Johan Bylund, David Goldblatt, (unknown)	1
18	David Goldblatt : South African intersections 2005 ·David Goldblatt, (unknown), (unknown), Michael Stevenson	1
19	Northern Consumption: A Critical Review of Issues, Driving Forces, Disciplinary Approaches and Critiques 1999 ·RePEc: Research Papers in Economics ·David Goldblatt	11
20	Treatment of amyotrophic lateral sclerosis. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·David Goldblatt	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact